Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: Teniposide
Trade Name: Vumon for injection
Date Designated: 11/01/1984
Orphan Designation: Treatment of refractory childhood acute lymphocytic leukemia.
Orphan Designation Status: Designated/Approved
Bristol-Myers Squibb Pharmaceutical Research Institute
5 Research Parkway
P.O. Box 5100
Wallingford, Connecticut 06492
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: Teniposide
Trade Name: Vumon for injection
Marketing Approval Date: 07/14/1992
Approved Labeled Indication: Induction therapy in patients with refractory childhood acute lymphoblastic leukemia when used in combination with other approved anticancer agents.
Exclusivity End Date: 07/14/1999 
Exclusivity Protected Indication* :  
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-